Cardiovascular risk assessment in osteoporotic patients using osteoprotegerin as a reliable predictive biochemical marker.
Barbu CG, Arsene AL, Florea S, Albu A, Sirbu A, Martin S, Nicolae AC, Burcea-Dragomiroiu GTA, Popa DE, Velescu BS, Dumitrescu IB, Mitrea N, Draganescu D, Lupuliasa D, Spandidos DA, Tsatsakis AM, Dragoi CM, Fica S.
Barbu CG, et al. Among authors: velescu bs.
Mol Med Rep. 2017 Nov;16(5):6059-6067. doi: 10.3892/mmr.2017.7376. Epub 2017 Aug 28.
Mol Med Rep. 2017.
PMID: 28849089
Free PMC article.
Clinical Trial.